Eterna Therapeutics
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $487 | $47 | $47 | $17 |
Gross Profit | 547 | -48 | -555 | -530 |
EBITDA | -24,455 | -4,151 | -5,316 | -5,288 |
EBIT | -24,906 | -4,729 | -5,857 | -5,769 |
Net Income | -26,604 | -5,529 | -6,647 | -6,153 |
Net Change In Cash | 487 | 47 | 47 | 17 |
Free Cash Flow | -6,304 | -2,508 | -3,848 | -4,680 |
Cash | 4,264 | 2,586 | 5,116 | 7,575 |
Basic Shares | 5,410 | 5,410 | 5,410 | 5,410 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $68 | $0 | $0 | $5,800 |
Gross Profit | -168 | -497 | -459 | -98 |
EBITDA | -19,934 | -33,217 | -121,947 | -7,150 |
EBIT | -21,057 | -33,714 | -122,406 | -7,248 |
Net Income | -21,668 | -24,579 | -122,306 | 11,906 |
Net Change In Cash | 68 | 0 | 0 | 5,800 |
Free Cash Flow | -20,427 | -21,273 | -23,642 | -8,140 |
Cash | 7,575 | 11,446 | 16,985 | 1,630 |
Basic Shares | 5,314 | 3,051 | 2,165 | 439 |
Earnings Calls
| Quarter | EPS |
|---|---|
2023-09-30 | -$1.03 |
2023-06-30 | -$0.85 |
2023-03-31 | -$1.24 |
2022-12-31 | -$1.24 |
